{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:12:33Z","timestamp":1791339153845,"version":"4.3.1"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2009,3,13]],"date-time":"2009-03-13T00:00:00Z","timestamp":1236902400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1000341","type":"journal-article","created":{"date-parts":[[2009,3,12]],"date-time":"2009-03-12T21:49:43Z","timestamp":1236894583000},"page":"e1000341","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":165,"title":["An Epstein-Barr Virus Anti-Apoptotic Protein Constitutively Expressed in Transformed Cells and Implicated in Burkitt Lymphomagenesis: The Wp\/BHRF1 Link"],"prefix":"10.1371","volume":"5","author":[{"given":"Gemma L.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianna","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Leese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew I.","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg W.","family":"Bornkamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan B.","family":"Rickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,3,13]]},"reference":[{"key":"ref1","first-page":"1397","article-title":"Epstein-Barr virus and Burkitt lymphoma.","volume":"60","author":"G Brady","year":"2007","journal-title":"J Clin Pathol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/asheducation-2007.1.277","article-title":"Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy.","volume":"2007","author":"GL Kelly","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1073\/pnas.93.19.10411","article-title":"c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.","volume":"93","author":"A Polack","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.","volume":"318","author":"JM Adams","year":"1985","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1084\/jem.192.8.1183","article-title":"Burkitt lymphoma in the mouse.","volume":"192","author":"AL Kovalchuk","year":"2000","journal-title":"J Exp Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2004-07-2573","article-title":"Deregulated expression of the Myc cellular oncogene drives development of mouse \u201cBurkitt-like\u201d lymphomas from naive B cells.","volume":"105","author":"D Zhu","year":"2005","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-230X(08)60470-4","article-title":"The pathogenesis of Burkitt's lymphoma.","volume":"55","author":"I Magrath","year":"1990","journal-title":"Adv Can Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.1096781","article-title":"Identification of virus-encoded microRNAs.","volume":"304","author":"S Pfeffer","year":"2004","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1371\/journal.ppat.0020023","article-title":"Epstein-Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially Expressed.","volume":"2","author":"X Cai","year":"2006","journal-title":"PLoS Pathog"},{"key":"ref10","first-page":"2511","article-title":"Fields Virology","author":"E Kieff","year":"2007"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1093\/nar\/14.17.7103","article-title":"Epstein-Barr virus mRNAs produced by alternative splicing.","volume":"14","author":"M Bodescot","year":"1986","journal-title":"Nucleic Acids Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1073\/pnas.85.11.3678","article-title":"Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes.","volume":"85","author":"PJ Austin","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1128\/JVI.61.9.2902-2909.1987","article-title":"Isolation and characterization of cDNA clones corresponding to transcripts from the BamHI H and F regions of the Epstein-Barr virus genome.","volume":"61","author":"AJ Pfitzner","year":"1987","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/335440a0","article-title":"Bcl-2 gene promotes haemopoietic cell survival and co-operates with c-myc to immortalise pre-B cells.","volume":"335","author":"DL Vaux","year":"1988","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0042-6822(87)90055-9","article-title":"Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex.","volume":"160","author":"GR Pearson","year":"1987","journal-title":"Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1371\/journal.pbio.0030404","article-title":"Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis.","volume":"3","author":"M Altmann","year":"2005","journal-title":"PLoS Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/j.1460-2075.1987.tb02568.x","article-title":"Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.","volume":"6","author":"M Rowe","year":"1987","journal-title":"EMBO J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"10565","DOI":"10.1073\/pnas.92.23.10565","article-title":"Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.","volume":"92","author":"BC Schaefer","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/JVI.70.1.623-627.1996","article-title":"Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.","volume":"70","author":"C Nonkwelo","year":"1996","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/nm758","article-title":"Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.","volume":"8","author":"G Kelly","year":"2002","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1093\/infdis\/171.5.1122","article-title":"Epstein-Barr virus co-infection and recombination in non-human- immunodeficiency virus-associated oral hairy leukoplakia.","volume":"171","author":"DM Walling","year":"1995","journal-title":"J Inf Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"7918","DOI":"10.1128\/JVI.68.12.7918-7926.1994","article-title":"The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.","volume":"68","author":"DM Walling","year":"1994","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature03845","article-title":"Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.","volume":"436","author":"MT Hemann","year":"2005","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.0401471101","article-title":"Bim is a suppressor of Myc-induced mouse B cell leukemia.","volume":"101","author":"A Egle","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1128\/JVI.68.9.6069-6073.1994","article-title":"Isolation of Epstein-Barr virus (EBV)-negative cell clones from the EBV-positive Burkitt's lymphoma (BL) line Akata: malignant phenotypes of BL cells are dependent on EBV.","volume":"68","author":"N Shimizu","year":"1994","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1128\/JVI.72.11.9150-9156.1998","article-title":"Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata.","volume":"72","author":"J Komano","year":"1998","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"9827","DOI":"10.1128\/JVI.73.12.9827-9831.1999","article-title":"Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata.","volume":"73","author":"J Komano","year":"1999","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"9977","DOI":"10.1128\/JVI.75.20.9977-9982.2001","article-title":"Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells.","volume":"75","author":"S Maruo","year":"2001","journal-title":"J Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"10223","DOI":"10.1128\/JVI.74.21.10223-10228.2000","article-title":"Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis.","volume":"74","author":"IK Ruf","year":"2000","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"14269","DOI":"10.1073\/pnas.2336099100","article-title":"Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.","volume":"100","author":"G Kennedy","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1084\/jem.20072581","article-title":"An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival.","volume":"205","author":"EY Choy","year":"2008","journal-title":"J Exp Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"10709","DOI":"10.1128\/JVI.79.16.10709-10717.2005","article-title":"Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.","volume":"79","author":"GL Kelly","year":"2005","journal-title":"J Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"14935","DOI":"10.1073\/pnas.0509988103","article-title":"Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.","volume":"103","author":"GL Kelly","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1093\/emboj\/19.12.3080","article-title":"The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.","volume":"19","author":"R Feederle","year":"2000","journal-title":"EMBO J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/JVI.63.1.445-449.1989","article-title":"Synchronous and sequential activation of latently infected Epstein-Barr virus genomes.","volume":"63","author":"K Takada","year":"1989","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1093\/nar\/gni137","article-title":"Stringent doxycycline-dependent control of gene activities using an episomal one-vector system.","volume":"33","author":"GW Bornkamm","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1099\/0022-1317-75-4-769","article-title":"Precipitation of the Epstein-Barr virus protein EBNA2 by an EBNA 3C-specific monoclonal antibody.","volume":"75","author":"MJ Maunders","year":"1994","journal-title":"J Gen Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1099\/vir.0.81906-0","article-title":"Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays.","volume":"87","author":"AI Bell","year":"2006","journal-title":"J Gen Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1182\/blood-2007-10-116269","article-title":"Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+ CD27+ B cells harbour the virus in X-linked lymphoproliferative disease patients.","volume":"112","author":"S Chaganti","year":"2008","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cyto.990210307","article-title":"Nucleic acid dyes for detection of apoptosis in live cells.","volume":"21","author":"T Frey","year":"1995","journal-title":"Cytometry"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.cdd.4400945","article-title":"Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells.","volume":"9","author":"AE Milner","year":"2002","journal-title":"Cell Death Differ"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2003-03-0930","article-title":"Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1.","volume":"103","author":"E Landais","year":"2004","journal-title":"Blood"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1128\/JVI.79.8.4896-4907.2005","article-title":"CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines.","volume":"79","author":"HM Long","year":"2005","journal-title":"J Virol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1128\/JVI.65.7.3821-3828.1991","article-title":"Identification of two T cell epitopes on the candidate Epstein- Barr virus vaccine glycoprotein gp340 recognised by CD4+ T cell clones.","volume":"65","author":"LE Wallace","year":"1991","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1128\/JVI.02435-06","article-title":"Truncated form of the Epstein-Barr virus protein EBNA-LP protects against caspase-dependent apoptosis by inhibiting protein phosphatase 2A.","volume":"81","author":"J Garibal","year":"2007","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.onc.1210668","article-title":"Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.","volume":"27","author":"E Anderton","year":"2008","journal-title":"Oncogene"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1128\/JVI.02244-06","article-title":"Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication.","volume":"81","author":"L Xing","year":"2007","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1073\/pnas.87.5.1725","article-title":"Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.","volume":"87","author":"M Woisetschlaeger","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1093\/nar\/14.17.7103","article-title":"Epstein-Barr virus mRNAs produced by alternative splicing.","volume":"14","author":"M Bodescot","year":"1986","journal-title":"Nucleic Acids Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1073\/pnas.83.14.5096","article-title":"Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: a probable transcriptional initiation site.","volume":"83","author":"J Sample","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1128\/JVI.01204-06","article-title":"Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.","volume":"80","author":"IA Hutchings","year":"2006","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"14062","DOI":"10.1128\/JVI.78.24.14062-14065.2004","article-title":"Variable methylation of the Epstein-Barr virus Wp EBNA gene promoter in B-lymphoblastoid cell lines.","volume":"78","author":"J Elliott","year":"2004","journal-title":"J Virol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1073\/pnas.90.18.8479","article-title":"Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death.","volume":"90","author":"S Henderson","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0006-291X(02)02261-1","article-title":"Epstein-Barr virus BHRF1 functions downstream of Bid cleavage and upstream of mitochondrial dysfunction to inhibit TRAIL-induced apoptosis in BJAB cells.","volume":"297","author":"M Kawanishi","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-4899-0274-0_9","article-title":"The Epstein-Barr virus gene BHRF1, a homologue of the cellular oncogene Bcl-2, inhibits apoptosis induced by gamma radiation and chemotherapeutic drugs.","volume":"406","author":"NJ McCarthy","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbamcr.2003.11.001","article-title":"Viral Bcl-2 homologs and their role in virus replication and associated diseases.","volume":"1644","author":"BM Polster","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1101\/gad.1012702","article-title":"Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection.","volume":"16","author":"A Cuconati","year":"2002","journal-title":"Genes Dev"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"12055","DOI":"10.1128\/JVI.76.23.12055-12068.2002","article-title":"Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses.","volume":"76","author":"P Rivailler","year":"2002","journal-title":"J Virol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/310207a0","article-title":"DNA sequence and expression of the B95-8 Epstein-Barr virus genome.","volume":"310","author":"R Baer","year":"1984","journal-title":"Nature"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1000341","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T18:56:04Z","timestamp":1589655364000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1000341"}},"subtitle":[],"editor":[{"given":"Jae U.","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,3,13]]},"references-count":59,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2009,3,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1000341","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,13]]}}}